These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23816857)

  • 1. Cardiovascular risk assessment using high-sensitivity C-reactive protein in patients with erectile dysfunction.
    Ferrandis-Cortes C; Martínez-Jabaloyas JM; Díez-Calzadilla NA; Hernández-Medina JA; Chuan-Nuez P
    Urol Int; 2013; 91(2):187-91. PubMed ID: 23816857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance of cardiovascular risk factors for outpatients in different erectile dysfunction severity.
    Chang ST; Chu CM; Hsu JT; Lin PC; Shee JJ
    Int J Impot Res; 2009; 21(2):116-21. PubMed ID: 19177147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone levels in men with erectile dysfunction.
    Martínez-Jabaloyas JM; Queipo-Zaragozá A; Pastor-Hernández F; Gil-Salom M; Chuan-Nuez P
    BJU Int; 2006 Jun; 97(6):1278-83. PubMed ID: 16686726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erectile dysfunction is associated with low bioactive testosterone levels and visceral adiposity in men with type 2 diabetes.
    Kapoor D; Clarke S; Channer KS; Jones TH
    Int J Androl; 2007 Dec; 30(6):500-7. PubMed ID: 18028199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erectile dysfunction is associated with low total serum testosterone levels and impaired flow-mediated vasodilation in intermediate risk men according to the Framingham risk score.
    Novo S; Iacona R; Bonomo V; Evola V; Corrado E; Di Piazza M; Novo G; Pavone C
    Atherosclerosis; 2015 Feb; 238(2):415-9. PubMed ID: 25562576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone deficiency in patients with erectile dysfunction: when should a higher cardiovascular risk be considered?
    Martínez-Jabaloyas JM;
    J Sex Med; 2014 Aug; 11(8):2083-91. PubMed ID: 24902756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of high-sensitivity C-reactive protein in a population of post-acute coronary syndrome patients receiving optimal medical treatment.
    Riedel M; Lafitte M; Pucheu Y; Latry K; Couffinhal T
    Eur J Prev Cardiol; 2012 Oct; 19(5):1128-37. PubMed ID: 21900366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-sensitivity C-reactive protein levels in HIV-infected patients treated or not with antiretroviral drugs and their correlation with factors related to cardiovascular risk and HIV infection.
    Guimarães MM; Greco DB; Figueiredo SM; Fóscolo RB; Oliveira AR; Machado LJ
    Atherosclerosis; 2008 Dec; 201(2):434-9. PubMed ID: 18359028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High sensitivity C-reactive protein and outcomes following percutaneous coronary intervention in contemporary practice.
    Herrmann J; Lennon RJ; Barsness GW; Sandhu GS; Gulati R; Best PJ; Sorajja P; Bresnahan JF; Mathew V; Bell MR; Prasad A
    Circ Cardiovasc Interv; 2012 Dec; 5(6):783-90. PubMed ID: 23212397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart rate and blood pressure interactions in the development of erectile dysfunction in high-risk cardiovascular patients.
    Kratz MT; Schumacher H; Sliwa K; Schmieder R; Pöss J; Mahfoud F; Unger T; Lonn E; Koon T; Mancia G; Sleight P; Yusuf S; Böhm M
    Eur J Prev Cardiol; 2014 Mar; 21(3):272-80. PubMed ID: 23818288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-sensitivity C-reactive protein predicts cardiovascular events and myocardial damage after vascular surgery.
    Scrutinio D; Passantino A; Di Serio F; Angiletta D; Santoro D; Regina G
    J Vasc Surg; 2011 Aug; 54(2):474-9. PubMed ID: 21458205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An association between body mass index and high-sensitivity C-reactive protein concentrations is influenced by age in community-dwelling persons.
    Kawamoto R; Kusunoki T; Abe M; Kohara K; Miki T
    Ann Clin Biochem; 2013 Sep; 50(Pt 5):457-64. PubMed ID: 23880621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between erectile dysfunction and cardiovascular risk in men with Type 2 diabetes in primary care: it is a matter of age.
    Cleveringa FG; Meulenberg MG; Gorter KJ; van den Donk M; Rutten GE
    J Diabetes Complications; 2009; 23(3):153-9. PubMed ID: 18413203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of lipid and inflammatory markers with C-reactive protein in cardiovascular risk assessment for primary prevention.
    Jovicić S; Ignjatović S; Dajak M; Kangrga R; Majkić-Singh N
    Clin Lab; 2009; 55(11-12):411-9. PubMed ID: 20225663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erectile dysfunction, obesity, insulin resistance, and their relationship with testosterone levels in eugonadal patients in an andrology clinic setting.
    Knoblovits P; Costanzo PR; Valzacchi GJ; Gueglio G; Layus AO; Kozak AE; Balzaretti MI; Litwak LE
    J Androl; 2010; 31(3):263-70. PubMed ID: 19834133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-sensitivity C-reactive protein is only weakly related to cardiovascular damage after adjustment for traditional cardiovascular risk factors.
    Olsen MH; Christensen MK; Hansen TW; Gustafsson F; Rasmussen S; Wachtell K; Borch-Johnsen K; Ibsen H; Jørgensen T; Hildebrandt P
    J Hypertens; 2006 Apr; 24(4):655-61. PubMed ID: 16531793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women.
    Maturana MA; Breda V; Lhullier F; Spritzer PM
    Metabolism; 2008 Jul; 57(7):961-5. PubMed ID: 18555838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association among hypogonadism, quality of life and erectile dysfunction in middle-aged and aged male in Taiwan.
    Hwang TI; Lo HC; Tsai TF; Chiou HY
    Int J Impot Res; 2007; 19(1):69-75. PubMed ID: 16688209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erectile dysfunction and testosterone screening with prostate specific antigen screening at age 40: are these three gender specific determinants additive for overall men's heath and do they improve traditional non-gender specific determinants to lessen cardiovascular risk and all-cause mortality?
    Miner MM; Seftel AD
    Int J Clin Pract; 2010 Dec; 64(13):1754-62. PubMed ID: 21070526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Erectile dysfunction and its severity are related to the number of cardiovascular risk factors].
    García-Cruz E; Piqueras M; Gosálbez D; Pérez-Márquez M; Peri L; Izquierdo L; Franco A; Luque P; Corral JM; Alvarez-Vijande R; Alcaraz A
    Actas Urol Esp; 2012 May; 36(5):291-5. PubMed ID: 22266257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.